Hajrulai-Musliu Zehra, Dimitreska Stojkovikj Elizabeta, Gusheski Dimitar, Musliu Dea, Velkovski Daniel
Faculty of Veterinary Medicine-Skopje, University "Ss. Cyril and Methodius", Lazar Pop-Trajkov 5/7, 1000 Skopje, North Macedonia.
FARMAHEM Dooel, Shar Planina 20, 1060 Skopje, North Macedonia.
Pharmacy (Basel). 2024 Dec 2;12(6):181. doi: 10.3390/pharmacy12060181.
The study highlights the need for quality control in evaluating medicinal plant products, especially CBD oils, before market release. Due to varying regulatory requirements, product labeling can sometimes be misleading, especially regarding cannabinoid concentrations such as CBD and THC. This research focused on developing a validated high-performance liquid chromatography (HPLC) method for accurately identifying and quantifying key cannabinoids in Commercial Veterinary CBD Oil. The main compounds identified included Cannabidivarin (CBDV), Cannabidiolic Acid (CBD-A), Cannabigerolic Acid (CBG-A), Cannabigerol (CBG), Cannabidiol (CBD), Tetrahydrocannabivarin (THCV), Cannabinol (CBN), ∆-Tetrahydrocannabinol (d9-THC) ∆8-Tetrahydrocannabinol (d8-THC), Cannabicyclol (CBL), Cannabichromene (CBC), and Tetrahydrocannabinolic Acid (THCA), determined in line with the International Conference on Harmonization's (ICH) guidelines. The method was validated for linearity, accuracy, precision, limit of detection (LOD), and limit of quantitation (LOQ). It was determined to be linear, with a correlation coefficient (R²) > 0.999. The LOD and LOQ values calculated from the calibration curve ranged from 0.05 to 0.13 and 0.50 to 0.61 µg/mL, respectively. The method also exhibited acceptable precision, with relative standard deviation values lower than or equal to 2%. The method's accuracy was assessed through recovery percentages and fell within an acceptable range of 98-102 if the RSD was 2%. This study's rigorous methodology and comprehensive findings significantly contribute to cannabinoid analysis. This validated protocol was used to analyze cannabinoids in 14 commercial veterinary CBD oil products from the Republic of North Macedonia. The performance parameters demonstrated that the method is reliable for quantitatively measuring cannabinoids in CBD oil. The analysis showed that the cannabinoid levels in the products were consistent with the manufacturers' declared specifications, with no significant discrepancies in labeling.
该研究强调了在药用植物产品,尤其是大麻二酚(CBD)油上市前进行质量控制的必要性。由于监管要求各不相同,产品标签有时可能会产生误导,尤其是在大麻素浓度(如CBD和四氢大麻酚(THC))方面。本研究着重开发一种经过验证的高效液相色谱(HPLC)方法,用于准确鉴定和定量商业兽医CBD油中的关键大麻素。鉴定出的主要化合物包括大麻二酚戊酸酯(CBDV)、大麻二酚酸(CBD-A)、大麻萜酚酸(CBG-A)、大麻萜酚(CBG)、大麻二酚(CBD)、四氢大麻二酚戊酸酯(THCV)、大麻酚(CBN)、Δ-四氢大麻酚(d9-THC)、Δ8-四氢大麻酚(d8-THC)、大麻二环醇(CBL)、大麻色烯(CBC)和四氢大麻酚酸(THCA),其测定符合国际协调会议(ICH)的指导原则。该方法在线性、准确性、精密度、检测限(LOD)和定量限(LOQ)方面均经过验证。结果表明该方法具有线性,相关系数(R²)>0.999。根据校准曲线计算出的LOD和LOQ值分别为0.05至0.13以及0.50至0.61μg/mL。该方法还具有可接受的精密度,相对标准偏差值低于或等于2%。通过回收率评估该方法的准确性,如果相对标准偏差为2%,则回收率在98-102%的可接受范围内。本研究严谨的方法和全面的结果对大麻素分析做出了重大贡献。该经过验证的方案用于分析来自北马其顿共和国的14种商业兽医CBD油产品中的大麻素。性能参数表明该方法对于定量测量CBD油中的大麻素是可靠的。分析表明,产品中的大麻素水平与制造商声明的规格一致,标签上没有明显差异。